Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-fentanyl-midazolam versus propofol-fentanyl-midazolam sedation in cataract surgery
IRCT20220817055733N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine, propofol, fentanyl and midazolam in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
ketaminepropofolfentanylmidazolam
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20220817055733N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220817055733N1.